Predictive factors for pacemaker requirement after transcatheter aortic valve implantation

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Akin, Ibrahim ^a   Kische, Stephan ^a   Paranskaya, Lylia ^a   Schneider, Henrik ^a   Rehders, Tim C ^a   Trautwein, Ulrich ^a   Turan, Gökmen ^a   Bänsch, Dietmar ^a   Thiele, Olga ^a   Divchev, Dimitar ^a   Bozdag Turan, Ilkay ^a   Ortak, Jasmin ^a   Kundt, Gunther ^a   Nienaber, Christoph A ^a   Ince, Hüseyin ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

AV block; His bundle; Left bundle branch block; Pacemaker; TAVI

Indexed keywords

CATECHOLAMINE;

AGED; AORTA VALVE STENOSIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART LEFT BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HUMAN; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; OPERATION DURATION; OUTCOME ASSESSMENT; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSTHESIS FAILURE; QRS COMPLEX; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE; CARDIAC CATHETERIZATION; ELECTROCARDIOGRAPHY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES;

EID: 84866917284     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-87     Document Type: Article

References (26)

1. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Leon MB, . PARTNER Trial Investigators Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012, 366:1696-1704. 10.1056/NEJMoa1202277, 22443478, PARTNER Trial Investigators.
2. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, . PARTNER Trial Investigators N Engl J Med 2012, 366:1686-1695. 10.1056/NEJMoa1200384, 22443479, PARTNER Trial Investigators.
3. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J, . German Transcatheter Aortic Valve Interventions-Registry Investigators Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011, 32:198-204. 10.1093/eurheartj/ehq339, 20864486, German Transcatheter Aortic Valve Interventions-Registry Investigators.
4. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007, 50:69-76. 10.1016/j.jacc.2007.04.047, 17601548.
5. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006, 112:842-850.
6. Bates MG, Matthews IG, Fazal IA, Turley AJ. Postoperative permanent pacemaker implantation in patients undergoing trans-catheter aortic valve implantation: what is the incidence and are there any predicting factors?. Interact Cardiovasc Thorac Surg 2001, 12:243-253.
7. Roques F, Nashef SA, Michel P, . EuroSCORE Project Group Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999, 15:816-822. 10.1016/S1010-7940(99)00106-2, 10431864, EuroSCORE Project Group.
8. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribrier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Piérard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, Von Segesser LK, Walther T, . European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Intervention (EAPCI). Eur Heart J 2008, 29:1463-1470. 10.1093/eurheartj/ehn183, 18474941, European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions.
9. Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011, 32:205-217. 10.1093/eurheartj/ehq406, 3021388, 21216739.
10. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere PP, Serruys PW. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv 2008, 1:310-316. 10.1016/j.jcin.2008.04.007, 19463319.
11. Baan J, Yong ZY, Koch KT, Henriques JP, Bouma BJ, Vis MM, Cocchieri R, Piek JJ, de Mol BA. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 2010, 159:497-503. 10.1016/j.ahj.2009.12.009, 20211315.
12. Calvi V, Puzzangara E, Pruiti GP, Conti S, Di Grazia A, Ussia GP, Capodanno D, Tamburino C. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 2009, 32(Suppl 1):S126-130.
13. Jilaihawi H, Chin D, Vasa-Nicotera M, Jeilan M, Spyt T, Ng GA, Bence J, Logtens E, Kovac J. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 2009, 157:860-866. 10.1016/j.ahj.2009.02.016, 19376312.
14. Piazza N, Nuis RJ, Tzikas A, Otten A, Onuma Y, Garcia-Garcia H, Schultz C, van Domburg R, van Es GA, van Geuns R, de Jaegere P, Serruys PW. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 2010, 6:475-484. 10.4244/EIJ30V6I4A80, 20884435.
15. El-Khally Z, Thibault B, Stainloae C, Theroux P, Dubuc M, Roy D, Guerra P, Macle L, Talajic M. Prognostic significance of newly accuired bundle branch block after aortic valve replacement. Am J Cardiol 2004, 94:1008-1011. 10.1016/j.amjcard.2004.06.055, 15476613.
16. Marchenese K, Schenk EA. Atrioventricular conduction system lesion following cardiac valve replacement. Circulation 1972, 45-46(Suppl. II):II 188.
17. Koplan BA, Stevenson WG, Epstein LM, Aranki SF, Maisel WH. Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery. J Am Coll Cardiol 2003, 41:795-801. 10.1016/S0735-1097(02)02926-1, 12628725.
18. Akin I, Kische S, Schneider H, Liebold A, Ortak J, Bänsch D, Rehders TC, Thiele O, Schneider R, Kundt G, Krenz H, Chatterjee T, Nienaber CA, Ince H. Surface and intracardiac ECG for discriminating conduction disorders after CoreValve implantation. Clin Res Cardiol 2012, 5:357-364.
19. Fraccaro C, Buja G, Tarantini G, Gasparetto V, Leoni L, Razzolini R, Corrado D, Bonato R, Basso C, Thiene G, Gerosa G, Isabella G, Iliceto S, Napodano M. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 2011, 107:747-754. 10.1016/j.amjcard.2010.10.054, 21247519.
20. Roten L, Wenaweser P, Delacretaz E, Hellige G, Stortecky S, Tanner H, Pilgrim T, Kadner A, Eberle B, Zwahlen M, Carrel T, Meier B, Windecker S. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 2010, 106:1473-1480. 10.1016/j.amjcard.2010.07.012, 21059439.
21. Ferreira ND, Caeiro D, Adão L, Oliveira M, Gonçalves H, Ribeiro J, Teixeira M, Albuquerque A, Primo J, Braga P, Simões L, Ribeiro VG. Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with self-expanding bioprosthesis. Pacing Clin Electrophysiol 2010, 33:1364-1372. 10.1111/j.1540-8159.2010.02870.x, 20723083.
22. Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder AJ, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali SS, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde JC, Hildick-Smith D. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributiong factors (the UK CoreValve Collaborative). Circulation 2011, 123:951-960. 10.1161/CIRCULATIONAHA.109.927152, 21339482.
23. Buellesfeld L, Stortecky S, Heg D, Hausen S, Mueller R, Wenaweser P, Pilgrim T, Gloekler S, Khattab AA, Huber C, Carrel T, Eberle B, Meier B, Boekstegers P, Jüni P, Gerckens U, Grube E, Windecker S. Impact of permanent pacemaker implantation on clinical outcome among patients undergoing transcatheter aortic valve implantation. J Am Coll Cardiol 2012, 60:493-501. 10.1016/j.jacc.2012.03.054, 22726632.
24. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, . American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 51:e1-62. 10.1016/j.jacc.2008.02.032, 18498951, American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons.
25. Erkapic D, Kim WK, Weber M, Möllmann H, Berkowitsch A, Zaltsberg S, Pajitnev DJ, Rixe J, Neumann T, Kuniss M, Sperzel J, Hamm CW, Pitschner HF. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 2010, 12:1188-1190. 10.1093/europace/euq094, 20353965.
26. Walther T, Falk V, Kempfert J, Borger MA, Fassl J, Chu MW, Schuler G, Mohr FW. Transapical minimally invasive aortic valve implantation; the intitial 50 patients. Eur J Cardiothorac Surg 2008, 33:983-988. 10.1016/j.ejcts.2008.01.046, 18294859.